San Jose, CA – According to filings with the U.S. Securities and Exchange Commission, Mendel Health is raising $40,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Karim Galil played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Mendel Health
At Mendel.ai, our mission is to use our novel AI aided by clinical experts to streamline global oncology research by organizing real world data and automating clinical trials. We build software to solve problems at each stage of the clinical trial process, from feasibility to post-trial pharmacovigilance. We strive for excellency, to be authentic and original, and to make a difference by greeting our challenges head on. Mendel is the brain child of Wael Salloum a computer scientist, and Karim Galil a physician. At their first meeting, Karim expressed that his dream as a physician was that every clinical expert mentioned have a Jarvis by their side an AI assistant that could scan all patient records and help them better personalize care for their patients. To his surprise, Wael mentioned that he had been working on a similar AI solution since 2005 the rest is history. Out of the Silicon Valley, the worlds center for innovation, they started Mendel.ai and secured funding from some of the worlds best VC firms to re-imagine the future of drug development and clinical practice.

To learn more about Mendel Health, visit http://www.mendel.ai/

Contact:
Karim Galil, Chief Executive Officer
415-528-9240
karim@mendel.ai
https://www.linkedin.com/in/karim-galil-m-d-83a2b258/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved